PharmaTher Holdings Ltd (TSE:PHRM) has released an update.
PharmaTher Holdings Ltd. has updated investors on the progress of its FDA New Drug Application for Ketamine, with a GDUFA goal date set for October 29, 2024. The FDA has indicated that no additional information is currently needed. The company is also planning for international approvals and novel uses of ketamine, addressing both the U.S. shortage and global medical needs.
For further insights into TSE:PHRM stock, check out TipRanks’ Stock Analysis page.
